|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A01N 43/02 | |
| A61K 31/335 | |||
| A61K 9/00 | |||
| A61K 47/12 | |||
| A61K 47/26 | |||
| A61K 9/19 |
| (11) | Number of the document | 2544537 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11754115.1 |
| Date of filing the European patent application | 2011-03-10 | |
| (97) | Date of publication of the European application | 2013-01-16 |
| (45) | Date of publication and mention of the grant of the patent | 2017-05-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/027984 |
| Date | 2011-03-10 |
| (87) | Number | WO 2011/112864 |
| Date | 2011-09-15 |
| (30) | Number | Date | Country code |
| 312417 P | 2010-03-10 | US |
| (72) |
PEREIRA, David, E., US
FERNANDES, Prabhavathi, US
|
| (73) |
Cempra Pharmaceuticals, Inc.,
6320 Quadrangle Drive, Suite 360, Chapel Hill, NC 27517,
US
|
| (54) | PARENTERAL FORMULATIONS OF MACROLIDE ANTIBIOTICS |
| PARENTERAL FORMULATIONS OF MACROLIDE ANTIBIOTICS |